The Pennant Group, Inc. (PNTG) fair value analysis

Nasdaq · Updated 2026-09-07

The Pennant Group, Inc. is a healthcare services company that operates skilled nursing facilities, assisted living facilities, and other senior care communities. The company operates facilities across multiple states in the United States.

Forward Fair Value verdict

Fairly valued

Based on TickrTrends' weekly Forward Fair Value model, PNTG is trading at within about 10% of estimated fair value.

PNTG currently ranks #79 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Fairly valued for 3 consecutive weekly runs.

Last price: $40.18
Sector: Healthcare
12-month range: $25.05–$40.18

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: D
Leverage: Moderate
RSI zone: Neutral
50/200-day trend: Uptrend
52-week position: The top quarter of its range

What our data shows for PNTG

Our model validated 17 trailing price-to-earnings windows for PNTG, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $25.05–$40.18.
The 14-day relative strength index sits at a neutral 47.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for PNTG
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent PNTG news

TickrTrends' derived news-sentiment signal for PNTG is currently leaning positive, computed from recent coverage.

Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference (manilatimes.net, 2026-09-01)
TickrTrends take: Pennant Group's participation in the Jefferies Healthcare Services Conference provides an opportunity for investors to assess management's strategic direction and operational updates against the company's current fairly valued status in the Healthcare sector. For valuation-focused readers, conference presentations often reveal management priorities regarding growth initiatives, cost management, and margin expansion that could justify any future valuation adjustments. Investors should monitor whether the company articulates specific operational improvements or market opportunities that might shift its valuation profile from its current fairly valued assessment.
The Pennant Group, Inc. (PNTG) Q2 2026 Earnings Call Transcript (seekingalpha.com, 2026-08-06)
TickrTrends take: The Pennant Group operates in the Healthcare sector and is currently assessed as fairly valued according to TickrTrends analysis. As the company discusses its Q2 2026 results, investors focused on valuation should monitor management commentary regarding operational efficiency, margin trends, and capital deployment, as these factors will be critical in determining whether the fairly valued assessment remains appropriate. Any material changes to growth trajectories or profitability metrics disclosed during the earnings call could shift the valuation context for the stock going forward.
The Pennant Group, Inc. (PNTG) Tops Q2 Earnings and Revenue Estimates (zacks.com, 2026-08-06)
TickrTrends take: The Pennant Group exceeded analyst expectations for second quarter earnings and revenue, which typically supports the case for companies to trade at premium valuations. Given TickrTrends' current assessment that PNTG is fairly valued despite this earnings beat, investors focused on valuation should monitor whether this outperformance leads to positive earnings revisions that might justify a higher valuation multiple in the Healthcare sector. The sustainability of these results and management's guidance for future quarters will be key factors in determining whether the current fair value assessment remains appropriate.

What people are saying

Follow the PNTG conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — TickrTrends' derived indicators for PNTG showed movement this week as the relative strength index shifted from oversold territory into neutral zone. The stock maintains a fairly valued assessment based on current valuation metrics. This change in the RSI zone suggests a technical rebalancing in the Healthcare sector name.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is PNTG stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), PNTG is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.

What is PNTG's TickrTrends verdict?

PNTG's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.

How does PNTG compare to other Healthcare stocks?

PNTG ranks #79 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is PNTG overbought or oversold?

PNTG's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

PNTG vs ABBV · PNTG vs ACHC · PNTG vs COR · PNTG vs ELV · PNTG vs HCSG